How many drugs treat Uterine fibroids?

Drug Landscape tracks 3 marketed treatments for Uterine fibroids (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/uterine-fibroids.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Uterine fibroids — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Uterine fibroids (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Uterine fibroids, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Yselty	LINZAGOLIX	Obseva Ireland Ltd		Gonadotropin-releasing hormone receptor	2022-01-01
Orgovyx	relugolix	MYOVANT SCIENCES	Gonadotropin Releasing Hormone Receptor Antagonist [EPC]	Gonadotropin-releasing hormone receptor	2020-01-01
Aygestin	NORETHINDRONE ACETATE	Duramed Res	Estrogen [EPC]	Progesterone receptor	1973-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 1 drug in Uterine fibroids
Duramed Res · 1 drug in Uterine fibroids
MYOVANT SCIENCES · 1 drug in Uterine fibroids
Obseva Ireland Ltd · 1 drug in Uterine fibroids

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Uterine fibroids:

Cite this brief

Drug Landscape (2026). Uterine fibroids — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/uterine-fibroids. Accessed 2026-06-10.

Uterine fibroids full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing